Center-Authored Papers

Filters: Author is Sung, Lillian  [Clear All Filters]
2009
Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S.  2009.  Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians.. Pediatrics. 123(3):1011-7. Abstract
2011
Tomlinson D, Bartels U, Gammon J, Hinds PS, Volpe J, Bouffet E, Regier DA, Baruchel S, Greenberg M, Barrera M et al..  2011.  Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals.. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 183(17):E1252-8. Abstract
Baker KS, Bhatia S, Bunin N, Nieder M, Dvorak CC, Sung L, Sanders JE, Kurtzberg J, Pulsipher MA.  2011.  NCI, NHLBI First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: State of the Science, Future Directions.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(10):1424-27.
2012
Ethier M-C, Regier DA, Tomlinson D, Judd P, Doyle J, Gassas A, Naqvi A, Sung L.  2012.  Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 20(8):1771-7. Abstract
Creutzig U, van den Heuvel-Eibrink MM, Gibson B, Dworzak MN, Adachi S, de Bont E, Harbott J, Hasle H, Johnston D, Kinoshita A et al..  2012.  Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel, on behalf of the AML Committee of the International BFM Study Group.. Blood. Abstract
Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK.  2012.  NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive Outcomes.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):162-71. Abstract
Sung L, Alibhai SM, Ethier M-C, Teuffel O, Cheng S, Fisman D, Regier DA.  2012.  Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia.. Journal of clinical epidemiology. 65(6):627-34. Abstract
Pulsipher MA, Skinner R, McDonald GB, Hingorani S, Armenian SH, Cooke KR, Gracia C, Petryk A, Bhatia S, Bunin N et al..  2012.  National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: The Need for Pediatric-S. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(3):334-47. Abstract
2013
Lee GE, Sung L, Fisher BT, Sullivan KE, McWilliams T, Tobias JW, Meshinchi S, Alonzo TA, Gamis A, Aplenc R.  2013.  Gene Expression Profiling to Predict Viridans Group Streptococcal and Invasive Fungal Infection in Pediatric Acute Myeloid Leukemia: A Brief Report from the Children's Oncology Group.. Acta haematologica. 131(3):167-169.
2014
Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L et al..  2014.  Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
2015
Tarlock K, Alonzo TA, Gerbing R, Raimondi SC, Hirsch BA, Sung L, Pollard JA, Aplenc R, Loken MR, Gamis A et al..  2015.  Gemtuzumab ozogamicin reduces relapse risk in FLT3/ITD acute myeloid leukemia: a report from the Children's Oncology Group.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Stokke J, Sung L, Gupta A, Lindberg A, Rosenberg AR.  2015.  Systematic review and meta-analysis of objective and subjective quality of life among pediatric, adolescent, and young adult bone tumor survivors.. Pediatric blood & cancer. 62(9):1616-29. Abstract
2016
Sung L, Aplenc R, Alonzo TA, Gerbing RB, Wang Y-C, Meshinchi S, Gamis AS.  2016.  Association between Prolonged Neutropenia and Reduced Relapse Risk in Pediatric AML: A Report from the Children's Oncology Group.. International journal of cancer. Abstract
Gerbing RB, Alonzo TA, Sung L, Gamis AS, Meshinchi S, Plon SE, Bertuch AA, Gramatges MM.  2016.  Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
2017
Vujkovic M, Attiyeh EF, Ries RE, Goodman EK, Ding Y, Kavcic M, Alonzo TA, Wang Y-C, Gerbing RB, Sung L et al..  2017.  Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.. Blood. Abstract
Tarlock K, Alonzo TA, Loken MR, Gerbing RB, Ries RE, Aplenc R, Sung L, Raimondi S, Hirsch BA, Kahwash SB et al..  2017.  Disease Characteristics and Prognostic Implications of Cell Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Guest EM, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Alonzo TA, Gerbing RB, Wang Y-CJ, Kahwash SB, Heerema-McKenney A et al..  2017.  Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials, AAML03P1 and AAML0531.. Blood.